ATH3G10

· Athera Biotechnologies AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATH3G10, covering 2021-05-03 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction [Phase 2]